Ranked by rounds participated in, from announcements in Jul 25, 2026 – Oct 22, 2026. Lead counts include only confirmed lead roles.
New companies 8 · Follow-on 0
Stages: Series A 3, Seed 2, Series B 2, Undisclosed 1
CarbonFarm €7M Series AEdonia €15M Series A financing package including non-dilutive and bank fundingEdison IA €1M SeedNew companies 4 · Follow-on 0
Stages: Seed 2, Pre-seed 1, Undisclosed 1
Verso $6M SeedCleavr €8M SeedOutline $3M Funding roundNew companies 3 · Follow-on 0
Stages: Undisclosed 3
Entalpic Undisclosed Planned strategic investmentGenesis AI Undisclosed Planned strategic investmentDoctolib Undisclosed Planned minority investmentNew companies 2 · Follow-on 1
Stages: Seed 2, Pre-seed 1
Verso $6M SeedCleavr €8M SeedShiplog $1M Pre-SeedNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Series A 1
Netsec >$10M UndisclosedRayon €10M Series ASorare >€10M Undisclosed equity financingNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Wavo €10M Equity financingActionable $10M Series ANew companies 2 · Follow-on 0
Stages: Undisclosed 2
Vates €30M First external growth investmentWiremind €35M First external financingNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Joe AI €2M UndisclosedLightspring €3.1M SeedNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Inbolt €11M €11 million funding roundHighLife €80M Financing roundNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Inbolt €11M €11 million funding roundZeliq €7M Seed extensionNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Rayon €10M Series AOpio €4M Funding roundNew companies 2 · Follow-on 0
Stages: Growth 1, Seed 1
RelaiSanté €6M SeedHomeExchange Undisclosed Growth investmentNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Delos €10M Series AOutline $3M Funding round“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.